P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL)

Detalles Bibliográficos
Autores principales: Kadia, T., Ravandi, F., Borthakur, G., Jabbour, E., Montalban-Bravo, G., Adewale, L., Pierce, S., Lacke, C., Brandt, M., Short, N., Jain, N., Burger, J., Ferrajoli, A., Wierda, W., Kantarjian, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429128/
http://dx.doi.org/10.1097/01.HS9.0000847640.27266.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429128/
http://dx.doi.org/10.1097/01.HS9.0000847640.27266.62

Ejemplares similares